AI Chat
Macro & News
Stocks
Alpha Lab
Utility
Menu
EN
Login
EN
Plunge Analysis
/
Sam Chun Dang Pharm Co., Ltd.
/
2026-04-22
▼ PLUNGE
Sam Chun Dang Pharm Co., Ltd.
-15.2%
000250
KRX
2026-04-22
403,000
Close
475,500
Prev Close
-15.25%
Change
4.7x
Vol Ratio
Why It Plunged
No related news available.
Related News
ImmuneOnco Completes Key Patient Enrollment in Phase III Trial of Lead Cancer Drug IMM01
Tipranks
2026-03-22
Sinopharm Defies Industry Headwinds With 2025 Profit Growth and Retail Turnaround
Tipranks
2026-03-22
Sanofi’s Amlitelimab Eczema Trial Reaches Completion, Setting Up a Key Pipeline Catalyst
Tipranks
2026-03-19
Shandong Xinhua Pharmaceutical Announces Retirement of Non-Executive Director
Tipranks
2026-03-31
Kynam Capital Sells $8.18M in Syndax Shares, Position Value Rises
Indexbox.Io
2026-03-21
Technical Analysis
Signals
MACD Bearish
Below SMA20
Key Indicators
32.94
RSI (14)
643075.00
SMA 20
162790.73
Bollinger Lower
1123359.27
Bollinger Upper
643075.00
Bollinger Mid
-86661.27
MACD
-67445.72
MACD Signal
-19215.55
MACD Hist
View Company
Back to Surge Stocks
Sam Chun Dang Pharm Co., Ltd. Surged +-15.2% on 2026-04-22 — Analysis | Alpha Lenz